Business & Industry

Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This move goes on to bring the Regulated Induced Proximity Targeting Chimera -RIPTAC platform from Halda to...

Understanding the critical role of containment isolators, biosafety cabinets, and specialized infrastructure in protecting operators and maintaining product integrity during high-potency API manufacturing requires examining regulatory frameworks, engineering controls, and facility design principles that define modern pharmaceutical safety standards.

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new voluntary access programme which aims to widen the usage of GLP-1 agonist medicines when it...

NICE has gone ahead and cleared the way for bevacizumab to be used by NHS in order to treat colorectal cancer for the very first time, all thanks to the availability when it comes to the lower-cost biosimilar versions...

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which already goes on to market an adult vaccine that protects against the hepatitis B virus...

Laboratory automation and robotics are redefining pharmaceutical R&D by eliminating manual errors, enabling high-throughput screening, and freeing scientists to focus on innovation through "lights-out" operations.